Vitamin D deficiency reduces the immune response, phagocytosis rate, and intracellular killing rate of microglial cells

Infection and Immunity

Volumn 82, Issue 6, 2014, Pages 2585-2594

  Djukic, Marija ^a,b   Onken, Marie Luise ^b   Schütze, Sandra ^b   Redlich, Sandra ^b   Götz, Alexander ^b   Hanisch, Uwe Karsten ^b   Bertsch, Thomas ^c   Ribes, Sandra ^b   Hanenberg, Andrea ^c   Schneider, Simon ^b   Bollheimer, Cornelius ^d,e   Sieber, Cornel ^d,e   Nau, Roland ^a,b  

^a Sleep Laboratory   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c KLINIKUM NÜRNBERG   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e Barmherzige Brüder Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; INTERLEUKIN 6; NITRIC OXIDE; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; CALCIFEDIOL; CHEMOKINE; CYTOKINE; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL INFECTION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; ESCHERICHIA COLI; IMMUNE RESPONSE; INFECTION RESISTANCE; INTRACELLULAR KILLING; MICROGLIA; MICROGLIAL CELL CULTURE; MOUSE; NEWBORN; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; AGONISTS; ANALYSIS OF VARIANCE; ANIMAL; BACTERIAL COUNT; BACTERIAL MENINGITIS; BLOOD; C57BL MOUSE; CELL CULTURE; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANALYSIS OF VARIANCE; ANIMALS; CALCIFEDIOL; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINES; COLONY COUNT, MICROBIAL; CYTOKINES; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; MENINGITIS, ESCHERICHIA COLI; MICE; MICE, INBRED C57BL; MICROGLIA; NITRIC OXIDE; PHAGOCYTOSIS; TOLL-LIKE RECEPTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84900431585     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01814-14     Document Type: Article

References (60)

1. Kalueff AV, Tuohimaa P. 2007. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr. Opin. Clin. Nutr. Metab. Care 10:12-19. http://dx.doi.org/10.1097/MCO.0b013e328010ca18.
2. Zittermann A. 2003. Vitamin D in preventive medicine: are we ignoring the evidence? Br. J. Nutr. 89:552-572. http://dx.doi.org/10.1079/BJN2003837.
3. Gloth FM, III, Gundberg CM, Hollis BW, Haddad JG, Jr, Tobin JD. 1995. Vitamin D deficiency in homebound elderly persons. JAMA 21: 1683-1686.
4. Holick MF. 2006. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin. Proc. 81:353-373. http://dx.doi.org/10.4065/81.3.353.
5. Flicker L, MacInnis RJ, Stein MS, Scherer SC, Mead KE, Nowson CA, Thomas J, Lowndes C, Hopper JL, Wark JD. 2005. Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J. Am. Geriatr. Soc. 53:1881-1888. http://dx.doi.org/10.1111/j.1532-5415.2005.00468.x.
6. Dusso AS, Brown AJ, Slatopolsky E. 2005. Vitamin D. Am. J. Physiol. Renal Physiol. 289:F8-F28. http://dx.doi.org/10.1152/ajprenal.00336.2004.
7. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. 2002. New clues about vitaminDfunctions in the nervous system. Trends Endocrinol. Metab. 13:100-105. http://dx.doi.org/10.1016/S1043-2760(01)00547-1.
8. McGrath J, Feron F, Eyles D, Mackay-Sim A. 2001. Vitamin D: the neglected neurosteroid? Trends Neurosci. 24:570-572. http://dx.doi.org/10.1016/S0166-2236(00)01949-4.
9. Prüfer K, Veenstra TD, Jirikowski GF, Kumar R. 1999. Distribution of 1,25-dihydroxyvitamin D 3 receptor immunoreactivity in the rat brain and spinal cord. J. Chem. Neuroanat. 16:135-145. http://dx.doi.org/10.1016/S0891-0618(99)00002-2.
10. Langub MC, Herman JP, Malluche HH, Koszewski NJ. 2001. Evidence of functional vitamin D receptors in rat hippocampus. Neuroscience 104: 49-56. http://dx.doi.org/10.1016/S0306-4522(01)00049-5.
11. Nagpal S, Na S, Rathnachalam R. 2005. Noncalcemic actions of vitamin D receptor ligands. Endocr. Rev. 26:662-687. http://dx.doi.org/10.1210/er.2004-0002.
12. Olliver M, Spelmink L, Hiew J, Meyer-Hoffert U, Henriques-Normark B, Bergman P. 6 August 2013. Immunomodulatory effects of vitamin D on innate and adaptive immune responses to Streptococcus pneumoniae. J. Infect. Dis. http://dx.doi.org/10.1093/infdis/jit355.
13. Rook GA, Steele J, Fraher L, Barker S, Karmali R, O'Riordan J, Stanford J. 1986. Vitamin D3,gammainterferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 57:159-163.
14. Hewison M. 2012. Vitamin D and immune function: an overview. Proc. Nutr. Soc. 71:50-61. http://dx.doi.org/10.1017/S0029665111001650.
15. Russo TA, Johnson JR. 2000. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J. Infect. Dis. 181:1753-1754. http://dx.doi.org/10.1086/315418.
16. Silver RP, Aaronson W, Vann WF. 1988. The K1 capsular polysaccharide of Escherichia coli. Rev. Infect. Dis. 10(Suppl 2):S282-S286. http://dx.doi.org/10.1093/cid/10.Supplement_2.S282.
17. Xie Y, Kim KJ, Kim KS. 2004. Current concepts on Escherichia coli K1 translocation of the blood-brain barrier. FEMS Immunol. Med. Microbiol. 42:271-279. http://dx.doi.org/10.1016/j.femsim.2004.09.001.
18. Aravalli RN, Peterson PK, Lokensgard JR. 2007. Toll-like receptors in defense and damage of the central nervous system. J. Neuroimmune Pharmacol. 2:297-312. http://dx.doi.org/10.1007/s11481-007-9071-5.
19. Laflamme N, Rivest S. 1999. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor κB alpha within specific cellular populations of the rat brain. J. Neurochem. 73:309-321. http://dx.doi.org/10.1046/j.1471-4159.1999.0730309.x.
20. Xu J, Ling EA. 1994. Upregulation and induction of surface antigens with special reference to MHC class II expression in microglia in postnatal rat brain following intravenous or intraperitoneal injections of lipopolysaccharide. J. Anat. 184:285-296.
21. Hanisch UK, Kettenmann H. 2007. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10:1387-1394. http://dx.doi.org/10.1038/nn1997.
22. Nau R, Bruck W. 2002. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci. 25:38-45. http://dx.doi.org/10.1016/S0166-2236(00)02024-5.
23. Simard AR, Rivest S. 2005. Do pathogen exposure and innate immunity cause brain diseases? Neurol. Res. 27:717-725. http://dx.doi.org/10.1179/016164105X49526.
24. Takeda K, Kaisho T, Akira S. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376. http://dx.doi.org/10.1146/annurev.immunol.21.120601.141126.
25. Häusler KG, Prinz M, Nolte C, Weber JR, Schumann RR, Kettenmann H, Hanisch UK. 2002. Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide and pneumococcal cell wallstimulated mouse microglia and macrophages. Eur. J. Neurosci. 16:2113-2122. http://dx.doi.org/10.1046/j.1460-9568.2002.02287.x.
26. Ribes S, Ebert S, Regen T, Agarwal A, Tauber SC, Czesnik D, Spreer A, Bunkowski S, Eiffert H, Hanisch UK, Hammerschmidt S, Nau R. 2010. Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia. Infect. Immun. 78:865-871. http://dx.doi.org/10.1128/IAI.01110-09.
27. Hewison M. 2011. Vitamin D and innate and adaptive immunity. Vitam. Horm. 86:23-62. http://dx.doi.org/10.1016/B978-0-12-386960-9.00002-2.
28. Ebert S, Gerber J, Bader S, Mühlhauser F, Brechtel K, Mitchell TJ, Nau R. 2005. Dose-dependent activation of microglial cells by Toll-like receptor agonists alone and in combination. J. Neuroimmunol. 159:87-96. http://dx.doi.org/10.1016/j.jneuroim.2004.10.005.
29. Walk RM, Elliot ST, Blanco FC, Snyder JA, Jacobi AM, Rose SD, Behlke MA, Salem AK, Vukmanovic S, Sandler AD. 2012. T-cell activation is enhanced by targeting IL-10 cytokine production in toll-like receptorstimulated macrophages. ImmunoTargets Ther. 1:13-23. http://dx.doi.org/10.2147/ITT.S32615.
30. Li P, Neubig RR, Zingarelli B, Borg K, Halushka PV, Cook JA, Fan H. 2012. Toll-like receptor-induced inflammatory cytokines are suppressed by gain of function or overexpression of Gα(i2) protein. Inflammation 35:1611-1617. http://dx.doi.org/10.1007/s10753-012-9476-z.
31. Ribes S, Ebert S, Czesnik D, Regen T, Zeug A, Bukowski S, Mildner A, Eiffert H, Hanisch UK, Hammerschmidt S, Nau R. 2009. Toll-like receptor prestimulation increases phagocytosis of Escherichia coli DH5alpha and Escherichia coli K1 strains by murine microglial cells. Infect. Immun. 77:557-564. http://dx.doi.org/10.1128/IAI.00903-08.
32. Ribes S, Adam N, Ebert S, Regen T, Bunkowski S, Hanisch UK, Nau R. 2010. The viral TLR3 agonist poly(I:C) stimulates phagocytosis and intracellular killing of Escherichia coli by microglial cells. Neurosci. Lett. 482: 17-20. http://dx.doi.org/10.1016/j.neulet.2010.06.078.
33. Kohchi C, Inagawa H, Nishizawa T, Soma G. 2009. ROS and innate immunity. Anticancer Res. 29:817-821.
34. Hewison M. 2011. Antibacterial effects of vitamin D. Nat. Rev. Endocrinol. 7:337-345. http://dx.doi.org/10.1038/nrendo.2010.226.
35. Bergman P, Norlin AC, Hansen S, Rekha RS, Agerberth B, Björkhem-Bergman L, Ekström L, Lindh JD, Andersson J. 2012. Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. BMJ Open. 2:e001663. http://dx.doi.org/10.1136/bmjopen-2012-001663.
36. Spina CS, Tangpricha V, Uskokovic M, Adorinic L, Maehr H, Holick MF. 2006. Vitamin D and cancer. Anticancer Res. 26:2515-2524.
37. Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D. 2008. Calciumindependent and 1,25(OH)2D3-dependent regulation of the reninangiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int. 74: 170-179. http://dx.doi.org/10.1038/ki.2008.101.
38. Adams JS, Hewison M. 2008. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metab. 4:80-90. http://dx.doi.org/10.1038/ncpendmet0716.
39. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M. 2001. Extrarenal expression of 25-hydroxyvitamin D(3)-1a-hydroxylase. J. Clin. Endocrinol. Metab. 86:888-894. http://dx.doi.org/10.1210/jcem.86.2.7220.
40. Janeway CA, Jr, Medzhitov R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216. http://dx.doi.org/10.1146/annurev.immunol.20.083001.084359.
41. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770-1773. http://dx.doi.org/10.1126/science.1123933.
42. Risso A. 2000. Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity. J. Leukoc. Biol. 68:785-792. http://dx.doi.org/10.1189/jlb.1938-3673.
43. Zanetti M. 2004. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75:39-48. http://dx.doi.org/10.1189/jlb.0403147.
44. Gombart AF, Saito T, Koeffler HP. 2009. Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates. BMC Genomics 10:321. http://dx.doi.org/10.1186/1471-2164-10-321.
45. Yim S, Dhawan P, Ragunath C, Christakos S, Diamond G. 2007. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J. Cyst. Fibros. 6:403-410. http://dx.doi.org/10.1016/j.jcf.2007.03.003.
46. Gombart AF, Borregaard N, Koeffler HP. 2005. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 19:1067-1077. http://dx.doi.org/10.1096/fj.04-3284com.
47. Evans KN, Nguyen L, Chan J, Innes BA, Bulmer JN, Kilby MD, Hewison M. 2006. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol. Reprod. 75:816-822. http://dx.doi.org/10.1095/biolreprod.106.054056.
48. Liu N, Kaplan AT, Low J, Nguyen L, Liu GY, Equils O, Hewison M. 2009. VitaminDinduces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol. Reprod. 80:398-406. http://dx.doi.org/10.1095/biolreprod.108.073577.
49. Lagishetty V, Misharin AV, Liu NQ, Lisse TS, Chun RF, Ouyang Y, McLachlan SM, Adams JS, Hewison M. 2010. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 151:2423-2432. http://dx.doi.org/10.1210/en.2010-0089.
50. Fexby S, Bjarnsholt T, Jensen PO, Roos V, Høiby N, Givskov M, Klemm P. 2007. Biological Trojan horse: antigen 43 provides specific bacterial uptake and survival in human neutrophils. Infect. Immun. 75: 30-34. http://dx.doi.org/10.1128/IAI.01117-06.
51. Sly LM, Lopez M, Nauseef WM, Reiner NE. 2001. 1α,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPHdependent phagocyte oxidase. J. Biol. Chem. 276:35482-35493. http://dx.doi.org/10.1074/jbc.M102876200.
52. Garcion E, Nataf S, Berod A, Darcy F, Brachet P. 1997. 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res. Mol. Brain Res. 45:255-267. http://dx.doi.org/10.1016/S0169-328X(96)00260-4.
53. Ehrchen J, Helming L, Varga G, Pasche B, Loser K, Gunzer M, Sunderkötter C, Sorg C, Roth J, Lengeling A. 2007. Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major. FASEB J. 21:3208-3218. http://dx.doi.org/10.1096/fj.06-7261com.
54. Keeney JT, Förster S, Sultana R, Brewer LD, Latimer CS, Cai J, Klein JB, Porter NM, Allan Butterfield D. 2013. Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: implications for low vitamin D-dependent age-related cognitive decline. Free Radic. Biol. Med. 18:324-334. http://dx.doi.org/10.1016/j.freeradbiomed.2013.07.019.
55. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC. 1985. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J. Immunol. 134:3032-3035.
56. Abbas AK, Murphy KM, Sher A. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-793. http://dx.doi.org/10.1038/383787a0.
57. Holick MF. 2007. Vitamin D deficiency. N. Engl. J. Med. 357:266-281. http://dx.doi.org/10.1056/NEJMra070553.
58. Peelen E, Knippenberg S, Muris AH, Thewissen M, Smolders J, Tervaert JW, Hupperts Damoiseaux RJ. 2011. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun. Rev. 10:733-743. http://dx.doi.org/10.1016/j.autrev.2011.05.002.
59. Hanisch UK. 2001. Microglia as a source and target of cytokine activities in the brain, p 79-124. In StreitWJ(ed), Microglia in the degenerating and regenerating CNS. Springer-Verlag, New York, NY.
60. Smith ME, van der Maesen K, Somera FP. 1998. Macrophage and microglial responses to cytokines in vitro: phagocytic activity, proteolytic enzyme release, and free radical production. J. Neurosci. Res. 54:68-78. http://dx.doi.org/10.1002/(SICI)1097-4547(19981001)54:1<68::AID-JN R8>3.0.CO;2-F.